Researchers predict that as baby boomers age, AD will affect as many as 14 million people nationwide. The causes of AD are not well understood, and there is presently no cure. However researchers are optimistic that future treatments will turn the illness into a manageable chronic condition. Today, research on genes that cause vulnerability to AD may shed light on the mechanisms of disease as well as other neurological disorders. The study is open to all individuals and family members with a suspected medical history of Alzheimer, and there is no cost to the participant.
Confidentiality is ensured.
Cloning of a novel gene bearing missense mutations in early onset familial Alzheimer disease. GeneSage seeks to feature IRB-approved, competitively funded programs in upcoming issues of GeneLetter. All material on this website is protected by copyright. GeneSage Inc. All rights reserved. This website also contains material copyrighted by third parties.